These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 6525902)

  • 21. Blood glucose, serum thyroid hormones, insulin, C-peptide and C-peptide/insulin ratio in hyperthyroid patients.
    Yamada T; Shirota T; Aizawa T; Takasu N
    Horm Metab Res; 1991 Oct; 23(10):504-5. PubMed ID: 1761283
    [No Abstract]   [Full Text] [Related]  

  • 22. [The effect of inderal on the heart of thyrotoxicosis patients (a clinico-roentgenologic study)].
    Astapov BM; Bogoliubov VM; Matveenko EG; Konstantinov IuN; Sorokina VG
    Klin Med (Mosk); 1972 Aug; 50(8):90-5. PubMed ID: 4660362
    [No Abstract]   [Full Text] [Related]  

  • 23. Propranolol in the treatment of thyrotoxicosis: a review.
    McDevitt DG
    Postgrad Med J; 1976; 52 Suppl 4():157-61. PubMed ID: 61585
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect of anaprilin on the indicators of central hemodynamics and excretion of catecholamines in patients with thyrotoxicosis].
    Ozerova MR; Levchenko TP
    Vrach Delo; 1976 Feb; (2):72-5. PubMed ID: 1266158
    [No Abstract]   [Full Text] [Related]  

  • 25. Electrocardiographic changes in hyperthyroidism after adrenergic blockade with reserpine and propranolol.
    Teoh PC; Cheah JS
    Med J Aust; 1973 Jul; 2(3):116-8. PubMed ID: 4730032
    [No Abstract]   [Full Text] [Related]  

  • 26. [Use of adrenergic beta blockaders in thyrotoxicosis and hypothyroidism].
    Feldstein CA; Duhart JE; Henry EC; Degrossi OJ
    Prensa Med Argent; 1970 May; 57(9):454-8. PubMed ID: 4397115
    [No Abstract]   [Full Text] [Related]  

  • 27. The role of selective beta 1-blocker in the preoperative preparation of thyrotoxicosis: a comparative study with propranolol.
    Vickers P; Garg KM; Arya R; Godha U; Mathur P; Jain S
    Int Surg; 1990; 75(3):179-83. PubMed ID: 2242971
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Compared effect of propranolol and acebutolol on serum thyroid hormones' levels in euthyroid and hyperthyroid patients: a randomized study.
    Perret G; Hugues JN; Modigliani E; Sebaoun J
    Int J Clin Pharmacol Ther Toxicol; 1984 Jul; 22(7):360-4. PubMed ID: 6469425
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Comparative values of protein-bound iodine, the in vitro thyroxine-binding protein capacity and blood cholesterol level in some diseases of the thyroid gland].
    Soumar J; Bednár J; Strasek J
    Endokrinologie; 1967; 52(3):216-27. PubMed ID: 4172943
    [No Abstract]   [Full Text] [Related]  

  • 30. Beta-adrenergic blockade in thyrotoxicosis.
    Pimstone BL
    S Afr Med J; 1969 Dec; ():Suppl:27-30. PubMed ID: 5372955
    [No Abstract]   [Full Text] [Related]  

  • 31. Markers of tissue response to thyroid hormones in patients with hyperthyroidism or hypothyroidism.
    Kucharz EJ; Marcisz C; Jonderko G; Jurecka-Tuleja B; Gołab T; Gina AR
    Rom J Intern Med; 1997; 35(1-4):71-5. PubMed ID: 9562655
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Blood serum triiodothyronine and lipid level in hyperthyroidism during short-term administration of small doses of propranolol].
    Lopatyński J; Tomaszewski J; Mardarowicz G; Dmoszyńska E
    Pol Arch Med Wewn; 1980 Oct; 64(4):317-25. PubMed ID: 7454595
    [No Abstract]   [Full Text] [Related]  

  • 33. The effects of propranolol, practolol, and placebo on the clinical manifestations of thyrotoxicosis.
    Chapdelaine A; Coulombe R; LeLorier J
    Int J Clin Pharmacol Biopharm; 1976 Dec; 14(4):308-12. PubMed ID: 794003
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of propranolol, atenolol and metoprolol on the serum levels of thyroxin (T4) and triiodothyronine (T3).
    Shikara MM; Maniar R; Steier W; Rao S; Gintautas J
    Proc West Pharmacol Soc; 2003; 46():127. PubMed ID: 14699907
    [No Abstract]   [Full Text] [Related]  

  • 35. [On preoperative and postoperative treatment of severe hyperthyroidism using propranolol].
    Höfer R; Keminger K; Kraupp O; Seidl H; Steinbereithner K
    Wien Med Wochenschr; 1969 Feb; 119(5):89-94. PubMed ID: 4182147
    [No Abstract]   [Full Text] [Related]  

  • 36. [Comparative study on the effects of carbimazole and propranolol in 131I-therapy of hypothyroidism].
    Aro A; Huttunen JK; Ikkala E; Kuusisto A; Lamberg BA; Pelkonen R; Rissanen V; Salmi J; Tervonen S
    Duodecim; 1980; 96(17):1125-34. PubMed ID: 7018875
    [No Abstract]   [Full Text] [Related]  

  • 37. [Thyrotoxic periodic paralysis as a form of presentation of primary autoimmune hyperthyroidism: utility of non-selective beta blockers].
    Fuertes Zamorano N; Foncillas CM; Novoa MP; Andrada AS; Cobos RG; Pérez JA
    Endocrinol Nutr; 2009; 56(6):348-51. PubMed ID: 19695518
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Oral propranolol in hypercalcemia associated with apathetic thyrotoxicosis.
    Shahshahani MN; Palmieri GM
    Am J Med Sci; 1978; 275(2):199-202. PubMed ID: 665723
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hyperthyroidism induced by amiodarone therapy].
    Sanz Moreno J; Plaza Canteli S; Melchor Iñíguez R; López Gil M; Gómez Pellico C; Gil Grande R; Valdivieso Varela L
    Med Clin (Barc); 1983 Apr; 80(14):615-8. PubMed ID: 6876919
    [No Abstract]   [Full Text] [Related]  

  • 40. Propranolol and serum calcium in thyrotoxicosis.
    Seedat YK; Vinik AI; Stewart-Wynne EG
    Br Med J; 1970 Aug; 3(5721):525-6. PubMed ID: 4195345
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.